Kronos Bio, Inc. (KRON)

USD 0.79

(1.58%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue 6.28 Million - - - - -
Cost of Revenue 4.91 Million 4.46 Million 4.08 Million 4.86 Million 605 Thousand 160 Thousand
Gross Profit 1.37 Million -4.46 Million -4.08 Million -4.86 Million -605 Thousand -160 Thousand
Operating Expenses 128.11 Million 137.11 Million 151.39 Million 58.04 Million 16.81 Million 6.64 Million
Selling, General and Administrative Expenses 41.73 Million 43.4 Million 38.49 Million 14.79 Million 3.37 Million 1.61 Million
Research and Development Expenses 86.37 Million 93.71 Million 112.9 Million 43.25 Million 13.44 Million 5.03 Million
Other Expenses - - - -27.4 Million - -
Cost and Expenses 128.11 Million 137.11 Million 151.39 Million 58.04 Million 16.81 Million 6.64 Million
Operating Income -121.83 Million -137.11 Million -151.39 Million -58.04 Million -16.81 Million -6.64 Million
Interest Expense - - - 3.89 Million - 76 Thousand
Income Tax Expense - -3.91 Million -1.97 Million -24.35 Million -699 Thousand -70.14 Thousand
Earnings before Tax -112.67 Million -133.2 Million -151.07 Million -88.44 Million -16.11 Million -6.72 Million
Net Income -112.67 Million -129.29 Million -149.1 Million -64.08 Million -15.41 Million -6.72 Million
Earnings Per Share Basic -1.95 -2.30 -2.72 -1.19 -0.29 -0.24
Earnings Per Share Diluted -1.95 -2.30 -2.72 -1.19 -0.29 -0.24
Weighted Average Shares Outstanding 57.74 Million 56.2 Million 54.75 Million 54.07 Million 53.04 Million 28.45 Million
Weighted Average Shares Outstanding (Diluted) 57.74 Million 56.2 Million 54.75 Million 54.07 Million 53.04 Million 28.45 Million
Gross Margin 0.22 - - - - -
EBIT Margin -19.38 - - - - -
Profit Margin -17.92 - - - - -
EBITDA -121.83 Million -128.74 Million -146.99 Million -79.68 Million -15.51 Million -6.48 Million
Earnings Before Tax Margin -19.38 - - - - -

Income Statement Charts